Journal
SCIENTIFIC REPORTS
Volume 9, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-019-43607-7
Keywords
-
Categories
Funding
- Interdisciplinary Center for Clinical Research (IZKF), Erlangen
- Innovative Medicines Initiative Joint Undertaking under EMIF from the European Union [115372]
- European Union
- German Research Foundation (DFG) [CRC1181]
- Ardea Biosciences, Inc.
- Deutsche Forschungsgemeinschaft (DFG)
- FriedrichAlexander-Universitat Erlangen-Nurnberg (FAU)
- Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Ask authors/readers for more resources
Microvesicles are small membranous particles generated during cellular activation or stress. The analysis of the content and the surface of microvesicles allow conclusions about the cells they are originating from and the underlying pathology. Therefore, CSF microvesicles have been suggested to be promising targets to monitor the (etio) pathology of neurodegenerative diseases. Microvesicles in the CSF of 15 patients with Alzheimer's disease and 15 controls were analyzed by flow cytometry regarding the levels of CD3, CD4, CD45, CD64, BACE1, A beta, APP and tau. The results were replicated in a second cohort comprising 14 patients with Alzheimer's disease and 9 controls. The levels of tau and APP were reduced in microvesicles of Alzheimer's disease patients. A significant change was neither observed in the number of microvesicles nor in the expression of the other antigens. Tau and APP in microvesicles separated patients with Alzheimer's disease from controls with an AUC of 0.84 and 0.89 respectively. We conclude that tau and APP in CSF microvesicles are promising biomarkers which could directly provide information about the Alzheimer pathology on a cellular level.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available